Vnitr Lek 2015, 61(7-8):655-659

Risk factors of thyroid carcinoma

Dana Nováková*, Martin Křenek, Květuše Vošmiková, Petr Vlček
Klinika nukleární medicíny a endokrinologie 2. LF UK a FN Motol Praha, přednosta prof. MUDr. Petr Vlček, CSc.

Thyroid cancer is one of the world's fastest growing tumor incidences. The number of new cases has particularly increased in differentiated papillary thyroid carcinoma. In the Czech Republic it is documented that the incidence of thyroid cancer continues to grow, since 1980 has increased four times. The Czech Republic has a higher incidence than most other European countries and at the same time is a country with average and declining mortality from this disease. This review summarizes the known risk factors that may contribute to the formation and rise of thyroid carcinomas.

Keywords: differentiated thyroid carcinoma; incidence; low risk carcinoma; microcarcinoma; risk factors

Received: February 2, 2015; Accepted: April 7, 2015; Published: July 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nováková D, Křenek M, Vošmiková K, Vlček P. Risk factors of thyroid carcinoma. Vnitr Lek. 2015;61(7-8):655-659.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aschebrook-Kilfoy B, Grogan RH, Ward MH et al. Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid 2013; 23(8): 1015-1021. Go to original source... Go to PubMed...
    2. Avanzi S, Alvisi G, Ripalti A. How virus persistence can initiate the tumorigenesis process. World J Virol 2013; 2(2): 102-109. Go to original source... Go to PubMed...
    3. Balkan F, Onal ED, Usluogullari A et al. Is there any association between insulin resistance and thyroid cancer? A case control study. Endocrine 2014; 45(1): 55-60. Go to original source... Go to PubMed...
    4. Brito JP, Yarur AJ, Prokop LJ et al. Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. Thyroid 2013; 23(4): 449-455. Go to original source... Go to PubMed...
    5. CDC 2010 Smoking and tobacco use. Chemical in Tobacco Smoke. Atlanta: CDC. Dostupné z WWW: <http://www.cdc.gov/tobacco/data_statistics/sgr/2010/consumer_booklet/chemicals_smoke/>.
    6. Choi WJ, Kim J. Dietary factors and the risk of thyroid cancer: a review. Clin Nutr Res 2014; 3(2): 75-88. Go to original source... Go to PubMed...
    7. Dijkstra B, Prichard RS, Lee A et al. Changing patterns of thyroid carcinoma. Ir J Med Sci 2007; 176(2): 87-90. Go to original source... Go to PubMed...
    8. Dvorkin S, Robenshtok E, Hirsch D et al. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 2013; 98(6): 2409-2414. Go to original source... Go to PubMed...
    9. Fallah M, Pukkala E, Tryggvadottir L et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullarythyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet 2013; 50(6): 373-382. Go to original source... Go to PubMed...
    10. Feldt-Rasmussen U. Iodine and cancer. Thyroid 2001; 11(5): 483-486. Go to original source... Go to PubMed...
    11. Fiore E, Rago T, Provenzale MA et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010; 17(1): 231-239. Go to original source... Go to PubMed...
    12. Grodski S, Brown T, Sidhu S et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008; 144(6): 1038-1043. Go to original source... Go to PubMed...
    13. Haber MH, Lipkovic P. Thyroid cancer in Hawaii. Cancer 1970; 25(5): 1224-1227. Go to original source... Go to PubMed...
    14. Handkiewcz-Junak D, Banasik T, Kolosza Z et al. Risk of malignant tumors in first-degree relatives of patients withdifferentiated thyroid cancer - a hospital based study. Neoplasma 2006; 53(1): 67-72. Go to PubMed...
    15. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351(17): 1764-1771. Go to original source... Go to PubMed...
    16. Howlader N, Noone A, Krapcho M et al. 2013 SEER Cancer Statistics Review, 1975-2010. Bethesda (MD): National Cancer Institute. Dostupné z WWW: http://seer.cancer.gov/csr/1975_2010. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
    17. Kabat GC, Kim MY, Wactawski-Wende J et al. Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control 2012; 23(12): 2031-2040. Go to original source... Go to PubMed...
    18. Konturek A, Barczyński M, Wierzchowski W et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg 2013; 398(3): 389-394. Go to original source... Go to PubMed...
    19. Krátký J, Vítková H, Bartáková J et al. Thyroid nodules: pathophysiological insight on oncogenesis and novel diagnostic techniques. Physiol Res 2014; 63(Suppl 2): S263-S275. Go to original source... Go to PubMed...
    20. Lehrer S, Rosenzweig KE. Cold Climate Is a Risk Factor for Thyroid Cancer. Clin Thyroidol 2014; 26(10): 273-276. Go to original source...
    21. Liu X, Zhu L, Cui D et al. Coexistence of Histologically Confirmed Hashimoto's Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort. Int J Endocrinol 2014; 2014: 769294. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/769294>. Go to original source... Go to PubMed...
    22. Lukas J, Drabek J, Lukas D et al. The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157(3): 266-275. Go to original source... Go to PubMed...
    23. Marcello MA, Malandrino P, Almeida JF et al. The influence of the environment on the development of thyroid tumors: a new appraisal. Endocr Relat Cancer 2014; 21(5): T235-T235. Go to original source... Go to PubMed...
    24. Mettler jr. FA, Bhargavan M, Thomadsen BR et al. Nuclear medicine exposure in the United States, 2005-2007: preliminary results. Semin Nucl Med 2008; 38(5): 384-391. Go to original source... Go to PubMed...
    25. Ondrusova M, Kajo K, Ondrus D. Changing patterns in thyroid cancer incidence and mortality in the Slovak Republic by histological type and age. Int J Clin Oncol 2014; 19(5): 805-813. Go to original source... Go to PubMed...
    26. Pellegriti G, Frasca F, Regalbuto C et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013: 965212. Dostupné z DOI: <http://dx.doi.org/10.1155/2013/965212>. Go to original source... Go to PubMed...
    27. Pellegriti G, De Vathaire F, Scollo C et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 2009; 101(22): 1575-1583. Go to original source... Go to PubMed...
    28. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One 2012; 7: e29177. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0029177>. Go to original source... Go to PubMed...
    29. Robbins J, Merino MJ, Boice jr. JD et al. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 1991; 115(2): 133-147. Go to original source... Go to PubMed...
    30. Ron E, Lubin JH, Shore RE et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141(3): 259-277. Go to original source...
    31. Tsai JH, Tsai CH, Cheng MH et al. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005; 75(2): 276-281. Go to original source... Go to PubMed...
    32. Tung-Sun Huang, Jie-Jen Lee, Shih-Ping Cheng. No evidence of association between human cytomegalovirus infection and papillary thyroid cancer. World J Surg Oncol 2014; 12: 41. Dostupné z DOI: <http://dx.doi.org/10.1186/1477-7819-12-41>. Go to original source... Go to PubMed...
    33. Wang F, Wang Y, Wang L et al. Strong association of high urinary iodine with thyroid nodule and papillary thyroid cancer. Tumour Biol 2014; 35(11): 11375-11379. Go to original source... Go to PubMed...
    34. Williams D. Cancer after nuclear fallout: lessons from the Chernobyl accident. Nat Rev Cancer 2002; 2(7): 543-549. Go to original source... Go to PubMed...
    35. Zafon C, Obiols G. The mitogen-activated protein kinase (MAPK) signaling pathway in papillary thyroid cancer. From the molecular bases to clinical practice. Endocrinol Nutr 2009; 56(4): 176-186. Go to original source... Go to PubMed...
    36. Zamora-Ros R, Rinaldi S, Biessy C et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study. Int J Cancer 2015; 136(5): 1218-1227. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.